SCHEMBL1694487

SCHEMBL1694487

CCC1(CC)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28200979 0.78
SCHEMBL7314602 0.76 ALPL (0.36)
SCHEMBL7076085 0.76
SCHEMBL28017232 0.69
SCHEMBL4328730 0.67
SCHEMBL18622046 0.67
SCHEMBL5839039 0.65
SCHEMBL17682032 0.65
SCHEMBL28017088 0.62 KDM4E (0.30)
SCHEMBL18881105 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112457203-B Preparation method of 2-amino-2-methyl-1-propanol 苏州亚科科技股份有限公司 2022-08-16 CN claimed
CN-112457203-A Preparation method of 2-amino-2-methyl-1-propanol 苏州亚科科技股份有限公司 2021-03-09 CN claimed
CN-112457203-B Preparation method of 2-amino-2-methyl-1-propanol 苏州亚科科技股份有限公司 2022-08-16 CN disclosed
CN-112457203-A Preparation method of 2-amino-2-methyl-1-propanol 苏州亚科科技股份有限公司 2021-03-09 CN disclosed
US-10478426-B2 Enhancer of Zeste Homolog 2 inhibitors GLAXOSMITHKLINE LLC (US) 2019-11-19 US disclosed
US-20180207144-A1 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS GLAXOSMITHKLINE LLC 2018-07-26 US disclosed
US-9956210-B2 Enhancer of zeste homolog 2 inhibitors GLAXOSMITHKLINE LLC (US) 2018-05-01 US disclosed
EP-3246027-A1 INDOLE DERIVATIVES FOR THE TREATMENT OF CANCER GlaxoSmithKline LLC (US) 2017-11-22 EP disclosed
US-9649307-B2 Indoles GLAXOSMITHKLINE LLC (US) 2017-05-16 US disclosed
US-20170095461-A1 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS GLAXOSMITHKLINE LLC 2017-04-06 US disclosed
EP-2755962-B1 AZAINDAZOLES GLAXOSMITHKLINE LLC (US) 2017-03-01 EP disclosed
US-20130059849-A1 AZAINDAZOLES GLAXOSMITHKLINE LLC 2013-03-07 US disclosed
US-20130053397-A1 INDOLES GLAXOSMITHKLINE LLC 2013-02-28 US disclosed
WO-2012075080-A1 INDOLES GLAXOSMITHKLINE LLC (US) 2012-06-07 WO disclosed
WO-2012005805-A1 AZAINDAZOLES GLAXOSMITHKLINE LLC (US) 2012-01-12 WO disclosed
WO-2011140324-A1 INDOLES GLAXOSMITHKLINE LLC (US) 2011-11-10 WO disclosed
WO-2010019204-A1 ANTIFUNGAL AGENTS MERCK SHARP & DOHME CORP. (US) 2010-02-18 WO disclosed
US-20090156807-A1 Anti-tumor Compounds Derived From 1,4,5,8-tetrachloroanthraquinone ISHMAEL D RICHARD 2009-06-18 US disclosed
EP-1242495-A1 BLOCKED POLYISOCYANATES CONTAINING PHENOLIC GROUPS Bayer Corporation (US) 2002-09-25 EP disclosed
WO-2001044341-A1 BLOCKED POLYISOCYANATES CONTAINING PHENOLIC GROUPS BAYER CORPORATION (US) 2001-06-21 WO disclosed